TScan Therapeutics (TCRX) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $1.00 from $7.00 | Sep 8, 2026 |
| Wedbush | Downgraded | Outperform → Neutral | $1.00 from $5.00 | Sep 3, 2026 |
| Needham | Downgraded | Buy → Hold | — | Sep 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Aug 12, 2026 |
| Needham | Maintained | Buy | $6.00 | Jun 23, 2026 |
| Wedbush | Maintained | Outperform | $5.00 | Jun 23, 2026 |
| Wedbush | Maintained | Outperform | $5.00 from $4.00 | Mar 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $10.00 | Nov 13, 2025 |
| Needham | Maintained | Buy | $6.00 from $9.00 | Nov 4, 2025 |
| BTIG | Downgraded | Buy → Neutral | — | Nov 4, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $15.00 | May 7, 2025 |
| Needham | Maintained | Buy | $9.00 | Apr 8, 2025 |
| Morgan Stanley | Initiated Coverage | Overweight | $10.00 | Mar 14, 2025 |
| Barclays | Maintained | Overweight | $3.00 from $14.00 | Mar 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Mar 6, 2025 |
| Needham | Maintained | Buy | $9.00 from $11.00 | Mar 5, 2025 |
| Needham | Maintained | Buy | $11.00 | Dec 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Dec 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Nov 15, 2024 |
| Needham | Maintained | Buy | $11.00 | Nov 12, 2024 |
Frequently asked questions
Is TCRX a buy, sell, or hold?
Analysts covering TScan Therapeutics currently average a Buy rating: 5 buy, 1 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TCRX?
On Sep 8, 2026, HC Wainwright & Co. downgraded TScan Therapeutics to Neutral with a price target of $1.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.